Cell Line : NCI-H69
Cellosaurus Index : CVCL_1579
Cellosaurus ID : NCI-H69
CTRP2 Name
: NCIH69
GDSC1 Name
, GDSC2 Name
: NCI-H69
CCLE Name
: NCIH69_LUNG
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H69 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H69 | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| NCI-H69 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H69 | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | AGI-6780 | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H69 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 4.0000 |
|
| NCI-H69 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| NCI-H69 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| NCI-H69 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H69 | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H69 | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| NCI-H69 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H69 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H69 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H69 | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| NCI-H69 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | AT7867 | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H69 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| NCI-H69 | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| NCI-H69 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| NCI-H69 | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H69 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| NCI-H69 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZD5582 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | AZD6482 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H69 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H69 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| NCI-H69 | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | BEC | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BI-2536 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| NCI-H69 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| NCI-H69 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| NCI-H69 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BMS-345541 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Bortezomib | GDSC1,GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| NCI-H69 | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H69 | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| NCI-H69 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 4.2000 |
|
| NCI-H69 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K16130065 | CTRP2 | 0.0020 | 8.3000 |
|
| NCI-H69 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K29086754 | CTRP2 | 0.0081 | 66.0000 |
|
| NCI-H69 | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K33199242 | CTRP2 | 0.0081 | 66.0000 |
|
| NCI-H69 | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K58730230 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H69 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K71781559 | CTRP2 | 0.0041 | 66.0000 |
|
| NCI-H69 | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K79669418 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H69 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K92856060 | CTRP2 | 0.0010 | 0.5200 |
|
| NCI-H69 | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD-K99584050 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H69 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| NCI-H69 | BRD4770 | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H69 | BRD55319 | CTRP2 | 0.0011 | 18.0000 |
|
| NCI-H69 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | BRD6430 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H69 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | BRD9647 | CTRP2 | 0.0041 | 33.0000 |
|
| NCI-H69 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| NCI-H69 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H69 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Cabozantinib | GDSC1,CTRP2 | 0.0200 | 66.0000 |
|
| NCI-H69 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H69 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H69 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H69 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H69 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H69 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| NCI-H69 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| NCI-H69 | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H69 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | CHIR-99021 | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H69 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| NCI-H69 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| NCI-H69 | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H69 | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| NCI-H69 | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| NCI-H69 | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H69 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| NCI-H69 | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| NCI-H69 | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Crizotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| NCI-H69 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H69 | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H69 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H69 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| NCI-H69 | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H69 | Daporinad | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.0000 |
|
| NCI-H69 | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Dasatinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H69 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H69 | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| NCI-H69 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| NCI-H69 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H69 | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H69 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| NCI-H69 | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H69 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H69 | Entinostat | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H69 | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | epigallocatechin-3-monogallate | CTRP2 | 0.0360 | 300.0000 |
|
| NCI-H69 | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| NCI-H69 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Erlotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| NCI-H69 | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| NCI-H69 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Fedratinib | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H69 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H69 | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H69 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Fulvestrant | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H69 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| NCI-H69 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0001 | 10.0000 |
|
| NCI-H69 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| NCI-H69 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| NCI-H69 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H69 | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H69 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | GSK269962A | GDSC1 | 0.0098 | 5.0000 |
|
| NCI-H69 | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H69 | GSK343 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H69 | GW843682X | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | I-BET-762 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | Imatinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H69 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H69 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| NCI-H69 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Irinotecan | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | isoliquiritigenin | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H69 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H69 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H69 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H69 | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| NCI-H69 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | KU 0060648 | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H69 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | Lapatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | LCL161 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H69 | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | LGK974 | GDSC1,GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H69 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | Luminespib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | manumycin A | CTRP2 | 0.0009 | 0.1200 |
|
| NCI-H69 | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| NCI-H69 | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| NCI-H69 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H69 | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| NCI-H69 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Mirin | GDSC1 | 0.3906 | 100.0000 |
|
| NCI-H69 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H69 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H69 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H69 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H69 | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H69 | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| NCI-H69 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Navitoclax | GDSC1,GDSC2,CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H69 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H69 | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H69 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | neopeltolide | CTRP2 | 0.0010 | 0.1300 |
|
| NCI-H69 | neratinib | CTRP2 | 0.0010 | 17.0000 |
|
| NCI-H69 | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Nilotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| NCI-H69 | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H69 | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H69 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H69 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H69 | Nutlin-3a | GDSC1,GDSC2 | 0.0080 | 10.0000 |
|
| NCI-H69 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | NVP-TAE684 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Obatoclax Mesylate | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| NCI-H69 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| NCI-H69 | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | OSI-930 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | PAC-1 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Paclitaxel | GDSC1,GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| NCI-H69 | Palbociclib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H69 | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H69 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | Parthenolide | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H69 | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H69 | PD0325901 | GDSC1,GDSC2 | 0.0003 | 2.5000 |
|
| NCI-H69 | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H69 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| NCI-H69 | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | Pevonedistat | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | PFI3 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H69 | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| NCI-H69 | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | pifithrin-alpha | CTRP2 | 0.0071 | 120.0000 |
|
| NCI-H69 | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Piperlongumine | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| NCI-H69 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | PLX-4720 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H69 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H69 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | purmorphamine | CTRP2 | 0.0180 | 150.0000 |
|
| NCI-H69 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| NCI-H69 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | QS11 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Rapamycin | GDSC1,GDSC2 | 0.0000 | 0.1000 |
|
| NCI-H69 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | RG-108 | CTRP2 | 0.0320 | 270.0000 |
|
| NCI-H69 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H69 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H69 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H69 | Ruxolitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0130 | 220.0000 |
|
| NCI-H69 | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H69 | Saracatinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| NCI-H69 | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H69 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H69 | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| NCI-H69 | Selumetinib | GDSC1,GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H69 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H69 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H69 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H69 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0730 | 150.0000 |
|
| NCI-H69 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H69 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H69 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H69 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H69 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0001 | 10.0000 |
|
| NCI-H69 | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H69 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H69 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H69 | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | SKI-II | CTRP2 | 0.0041 | 66.0000 |
|
| NCI-H69 | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.3000 |
|
| NCI-H69 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H69 | Sorafenib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H69 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Sunitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| NCI-H69 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| NCI-H69 | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Tanespimycin | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | Taselisib | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H69 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Temsirolimus | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| NCI-H69 | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | TGX221 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| NCI-H69 | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H69 | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| NCI-H69 | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Tivozanib | GDSC1,CTRP2 | 0.0005 | 33.0000 |
|
| NCI-H69 | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H69 | Tozasertib | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H69 | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | Tretinoin | GDSC1,CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H69 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| NCI-H69 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | triptolide | CTRP2 | 0.0000 | 0.0011 |
|
| NCI-H69 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | Tubastatin A | GDSC1,CTRP2 | 0.0320 | 33.0000 |
|
| NCI-H69 | TW 37 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H69 | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | UNC0638 | GDSC1,GDSC2,CTRP2 | 0.0010 | 40.0000 |
|
| NCI-H69 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| NCI-H69 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H69 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| NCI-H69 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H69 | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H69 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H69 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H69 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H69 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H69 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H69 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H69 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | Wnt-C59 | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| NCI-H69 | XAV939 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H69 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H69 | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| NCI-H69 | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H69 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H69 | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H69 | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H69 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| NCI-H69 | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H69 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H69 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H69 | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC